GRAIL, Inc. (GRAL) Current Ratio
- Current ratio · latest quarter: Value 10.95×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 10.95× | Current assets / current liabilities. $914.72M ÷ $83.54M ≈ 10.95× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 914.72M USD | Assets, Current |
| Current obligations | 83.54M USD | Liabilities, Current |
| Cash and equivalents | 55.65M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 19.76M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 7.24M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $914.72M | $83.54M | $55.65M | (m) | $19.76M | (m) | $7.24M | (m) | 10.95× |
| 2026-03-31 | $877.35M | $74.71M | $69.34M | (m) | $20.34M | (m) | $4.67M | (m) | 11.74× |
| 2025-12-31 | $953.85M | $79.67M | $249.73M | (m) | $18.30M | (m) | $2.08M | (m) | 11.97× |
| 2025-09-30 | $589.38M | $77.43M | $126.89M | (m) | $16.28M | (m) | $3.41M | (m) | 7.61× |
| 2025-06-30 | $651.84M | $70.64M | $127.43M | (m) | $16.31M | (m) | $6.28M | (m) | 9.23× |
| 2025-03-31 | $727.65M | $74.98M | $133.90M | (m) | $19.31M | (m) | $5.77M | (m) | 9.71× |
| 2024-12-31 | $819.86M | $76.92M | $214.23M | (m) | $20.31M | (m) | $4.84M | (m) | 10.66× |
| 2024-09-30 | $909.70M | $94.27M | $853.55M | (m) | (m) | (m) | (m) | (m) | 9.65× |
| 2024-06-30 | $1.02B | $88.18M | $958.85M | (m) | (m) | (m) | (m) | (m) | 11.55× |
| 2023-12-31 | $156.06M | $163.61M | $97.29M | (m) | $16.94M | (m) | $19.67M | (m) | 0.95× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |